Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Sep 07, 2021 7:00 PM - Sep 10, 2021 12:30 AM

4051 Basel, Switzerland

Pharmacovigilance Strategies Workshop

Navigating the changing PV landscape in your daily work. Anniversary edition: 5 years

Session 2: Pharmacovigilance Changes In The UK

Session Chair(s)

Shahin  Kauser

Shahin Kauser

Leading Senior Scientific Assessor

MHRA, United Kingdom

This session will cover the new requirements for pharmacovigilance procedures such safety signals, safety reviews, variations, Periodic Safety Update Reports (PSUR) and Risk Management Plans in the UK following the end of the Brexit transition period. A regulator and the industry perspective will be given. The session aims to provide delegates with professional working knowledge of the UK PV requirements and an overview of the processes and procedures to help ensure compliance. Delegates will also have the opportunity to submit questions for the panel discussion at the end.


Anne M Ambrose, MPharm, MSc, RPh, RAC

PV and Risk Management planning developments in the UK - Industry Perspective: Anne M Ambrose, MPharm, MSc, RPh, RAC

Specialist in Post Authorisation Operations and Safety Issues

Medicines & Healthcare Products Regulatory Agency, United Kingdom

Paul  Knights

Variations between Northern Ireland and Great Britain: Industry Perspective: Paul Knights

Senior Director, Head Pharmacovigilance Strategy Policy & Standards and UK QPPV

Pfizer, United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.